EPEMED and other EU organisations support the Luxembourg European Presidency to making PM a EU health priority
For the twelfth time in its history, Luxembourg took over the European Union presidency on July 1st for 6 months.
The presidency established Personalised Medicine as one of its health policy priorities. It is in this context that the Luxembourg Ministry of Health opens tomorrow a rich agenda of presidency events with a one day high level conference to elaborate on “Making Access to Personalised Medicine a Reality for Patients”.
This closed event will bring together attendees drawn from public health decision makers, representatives from the Commission, Members of the European Parliament, Patient and European umbrella organizations representing interest groups and associations actively engaged in the field of Personalised Medicine.
« It is necessary to formulate a patient centered strategy involving EU decision makers and regulators in the arena of public health, to enable EU and Member States to contribute to integrating Personalised Medicine into clinical practice while enabling much-greater access for patients » said Anne Calteux, Senior Policy Advisor to the Luxembourg Minister of Health.
Patients’ concerns, expectations and priorities will be thus at the center of a cross-sectoral, highly relevant and dynamic discussion forum.
EPEMED is honoured to count amongst the senior delegates leading the program. Emmanuelle Benzimra, EPEMED General Delegate, will chair the session « adressing known obstacles to integrating PM into health systems ». In addition, Peter Kapitein, President of Inspire2Live and EPEMED member, will be one of the speakers intervening on the panel « the voice of the patients »
The conference’s main results will feed into draft Council conclusions which will be submitted to health ministers during the EPSCO Council on the 8th of December for adoption.
« With the Netherlands addressing access to innovative medicines as one the health priorities during their Presidency, the fundamental topic of Personalised Medicine will remain on the political agenda » advised Lydia Mutsch, Luxembourg Minister of Health.
Alain Huriez, MD EPEMED Founder and Chairman, trusts that « EPEMED will contribute to a major and decisive moment for future European strategic reflections in the field of Personalised Medicine ».